Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in <i>BRD4-NUTM1</i> NUT Carcinoma Harboring a <i>BRD4</i> Splice Site Mutation
Michael L. Cheng(Harvard University), Christopher A. French(Brigham and Women's Hospital)
Cited by 7
Related Papers
Ectopic protein interactions within BRD4–chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma
|Proceedings of the National Academy of Sciences|2017|141
The Importance of Diagnosing NUT Midline Carcinoma
|Head and Neck Pathology|2013|121
The BRD4–NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma
|Cancer Research|2023|37
NUTM1-rearranged Carcinoma of the Thyroid
|The American Journal of Surgical Pathology|2022|27